论文部分内容阅读
目的对复发性脑梗死合并高血压患者首次发病后使用降压药情况的调查,探讨引起其临床应用不规范的一些主要原因。方法从某院2005年9月～2011年6月住院的639例脑梗死患者中筛选出复发性脑梗死合并高血压102例,调查其住院前使用降压药的情况,分析降压药使用不规范的原因。结果 102例复发性脑梗死合并高血压患者75例(73.53%)患者降压药使用不规范;其中,47例(46.08%)患者虽坚持服用,但32例患者血压未达标占68.09%(32/47);21例(20.59%)患者间断服用降压药;7例(6.86%)患者未服用降压药;降压药使用不规范的主要原因为:患者担心不良反应;患者对高血压认识不足;患者或家属认为无效;患者未坚持内科门诊随访,未接受专科医生指导;门诊医生随访中忽略询问使用情况;患者嫌麻烦;患者因出现副作用而停药。结论相当比例的脑梗死合并高血压患者使用降压药不规范及未能坚持长期服用,降压达标率较低。应对脑梗死合并高血压患者加强脑卒中及高血压健康教育,以提高降压药使用依从性。
Objective To investigate the use of antihypertensive drugs in patients with recurrent cerebral infarction complicated with hypertension and to find out some of the main reasons leading to their non-standard clinical application. Methods A total of 102 patients with recurrent cerebral infarction complicated with hypertension were selected from 639 patients with cerebral infarction hospitalized from September 2005 to June 2011 in a hospital. The use of antihypertensive drugs before hospitalization was investigated. The use of antihypertensive drugs was not analyzed The reason for the specification Results Of the 102 patients with recurrent cerebral infarction complicated with hypertension, 75 (73.53%) patients had irregular use of antihypertensive drugs. Of these, 47 (46.08%) patients insisted on taking antihypertensive drugs, but 32 (68.09% / 47); 21 patients (20.59%) discontinued taking antihypertensive drugs intermittently; 7 patients (6.86%) did not take antihypertensive drugs; the main reasons for the nonstandard use of antihypertensive drugs were: patients were worried about adverse reactions; Lack of understanding; patients or their families considered invalid; patients did not adhere to medical out-patient follow-up, did not receive specialist guidance; outpatient follow-up neglected to ask the use of the situation; patients feel trouble; patients with side effects due to withdrawal. Conclusions A considerable proportion of patients with cerebral infarction and hypertensive patients who use antihypertensive drugs are not standardized and have not been able to adhere to long-term use, with a low compliance rate of blood pressure lowering. Response to cerebral infarction patients with hypertension to enhance stroke and hypertension health education to improve antihypertensive drug use compliance.